DUBLIN, Sept. 14, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/gxcc4k/global_vaccine) has announced the addition of the "Global Vaccine Partnering 2010-2015: Deal trends, players and financials" report to their offering.
The Global Vaccine Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.
This report contains a comprehensive listing of all vaccine partnering deals announced since January 2009, including financial terms where available, including over 1,000 links to online deal records of actual vaccine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The report takes readers through the vaccine deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering vaccine partnering deals.
The report presents average financial deal terms values for vaccine deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
Global Vaccine Partnering 2010-2015 includes:
- Trends in vaccine dealmaking in the biopharma industry since 2010
- Analysis of vaccine deal structure
- Access to headline, upfront, milestone and royalty data
- Case studies of real-life vaccine deals
- Access to over 800 vaccine deal documents
- The leading vaccine deals by value since 2010
- Most active vaccine dealmakers since 2010
- The leading vaccine partnering resources
In Global Vaccine Partnering 2010-2015, the available contracts are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Therapy target
- Specific technology type
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in vaccine dealmaking
Chapter 3 - Average financial deal terms for vaccine partnering
Chapter 4 - Leading vaccine deals
Chapter 5 - Vaccine contracts dealmaking directory
Chapter 6 - Vaccine dealmaking directory by technology type
Chapter 7 - Vaccine partnering resource center
Companies Mentioned - 34 of the 100+ Companies Featured
- Abbott
- AVI Pharma
- Avimex
- Dana-Farber Cancer Institute
- Defense Threat Reduction Agency
- Dendreon
- Department of Health and Human Services
- GlaxoSmithKline
- GlaxoSmithKline Biologicals
- GlobeImmune
- Gynecologic Oncology Group
- Heat Biologics
- Henry Schein
- Hollister-Stier Labs
- IBioPharma
- ID Biomedical
- ImmunoCellular Therapeutics
- Inovio Pharmaceuticals
- Isconova
- ISSI-Strategy
- Janssen Alzheimer Immunotherapy
- Janssen Pharmaceutica NV
- Johnson & Johnson
- Kirin Pharma
- Kyowa Hakko Kirin
- LG Life Sciences
- Lundbeck
- Maxygen
- Ohio State University
- Omnimmune
- OncoSec Medical
- Ortho-McNeil
- Otsuka
- Xencor
For more information visit http://www.researchandmarkets.com/research/gxcc4k/global_vaccine
Media Contact:
Laura Wood, +353-1-481-1716, press@researchandmarkets.net
Share this article